Lorcaserin Extended-Release Tablets and Scopolamine
Determining the interaction of Lorcaserin Extended-Release Tablets and Scopolamine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: scopolamine
Brand name: Transderm-Scop
Synonyms: Scopolamine transdermal, Scopolamine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Scopolamine (Systemic)
- Lorcaserin Extended-Release Tablets-Scopolamine Hydrobromide
- Lorcaserin Extended-Release Tablets-Scopolamine Injection
- Lorcaserin Extended-Release Tablets-Scopolamine Patch
- Lorcaserin Extended-Release Tablets-Scopolamine transdermal
- Lorcaserin Extended-Release Tablets-Scopolamine Transdermal Patch
- Scopolamine-Lorcaserin Hydrochloride
- Scopolamine-Lorcaserin Tablets
- Scopolamine-Lorcet
- Scopolamine-Lorcet Plus
- Scopolamine-Lorcet Tablets
- Scopolamine-Lorlatinib